A Phase 3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of BBP-418 (ribitol) in Patients with Limb Girdle Muscular Dystrophy 2I (LGMD2I)
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/brain-nervous.jpg)
Details
Age
Child to Adult
Locations
CTRC Inpatient
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
![Photograph of Varun Sreenivasan](https://researchstudies.cuanschutz.edu/Content/images/investigators/no-photo.jpg)
Varun Sreenivasan
Study ID
Protocol Number: 23-0309
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers